RapidAI のアプリ分析 1月9日
RapidAI
- ISchemaview, Inc.
- Apple App ストア
- 無料
- 医学
RapidAI is the world leader in AI-driven medical imaging analysis and coordinated care. With the industry’s most validated clinical AI platform, we empower care teams to rapidly, precisely, and confidently manage life-threatening conditions. Trusted by thousands of hospitals in 100+ countries, RapidAI delivers the deepest level of clinical decision support on the market to help accelerate the time to treatment and enhance patient outcomes. We go beyond the algorithm to drive care team collaboration and efficiencies that expand access to life-saving interventions. At RapidAI, we establish new standards for care teams and the patients they treat.
Physicians save precious time with anywhere, anytime notifications of new patient cases and access to RapidAI results and patient imaging on their mobile device.
Rapid Mobile App Features:
- Real-time notifications of new case events and messages
- Access to RapidAI results and patient images in as few as 90 seconds of a patient scan
- Source file viewing through a powerful DICOM viewer
- Full screen zoom functionality and landscape mode
- Image rotation for axial, coronal and sagittal views
- View and organize case results from multiple sites
- Flexible configuration options for PHI, biometrics, Single Sign-on and multi-factor authentication
- Centralized views of patient events, messages, and results
- Fast notification and coordination of stroke teams for critical cases
- Simple entry of key clinical information and ability to upload photos to the message feed
- In-app calling for quicker communications with stroke team members
RapidAI is not for diagnostic decision making. Refer to the PACS or clinical system for case evaluation.
ストアランキング
ストアランキングは、GoogleとAppleが設定した複数のパラメータに基づいています。
業界別 ウェブサイトカテゴリーで
米国--
医学で
米国--
アカウントを作成して平均月間ダウンロード数を見るお問い合わせはこちら
RapidAI時間の経過に伴う ランキングの統計
Similarwebの使用ランクとRapidAI向けApple App ストアランク
ランキング
ご利用可能なデータがありません
RapidAIの国別ランキング
メインカテゴリ RapidAI で最もランクが高い郡
表示できるデータはありません
1月 9, 2026